Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Andrew M. Dahl

At a glance: Andrew M. Dahl is Svp, Corporate Controller at Edwards Lifesciences (EW). Their latest SEC Form 4, filed Aug 31, 2026, reported a sale of $50K. On file: 0 purchase lines ($0) and 2 sale lines ($98K).

Disclosed holdings: about $1.5M of EW stock: 14,868 shares reported on their latest Form 4 (filed Aug 31, 2026), valued at the Nov 19, 2026 close of $103.72. This counts only EW shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.

Svp, Corporate Controller at Edwards Lifesciences Corp (EW)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $98K

Andrew M. Dahl's InsiderPrint

2 trades from SEC Form 4 filings, 2026 to 2026, drawn as one fingerprint.

InsiderPrint of Andrew M. Dahl: 2 trades, 2026 to 20262026: 0 buys, 2 sales
  • Bump outward: a purchase (0)
  • Dent inward: a sale (2)
  • One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.

Reported trades

Filed Stock Type Shares Price Value Since
Aug 31SEC EWEdwards Lifesciences Corp Sell 54414,868 held (−4%) $91.06 $50K +13.9%
May 29SEC EWEdwards Lifesciences Corp Sell 56815,334 held (−4%) $86.08 $49K +20.5%

Follow Andrew M. Dahl

Get one email when Andrew M. Dahl files a new purchase or sale. Free.

At most one email a day about Andrew M. Dahl, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.